Il Tempo: Regeneron consolida la presenza in Italia e apre nuovi uffici a Milano
Regeneron consolida la presenza in Italia e apre nuovi uffici a Milano
Regeneron strengthens its presence in Italy and opens new offices in Milan.
Regeneron strengthens its presence in Italy and opens new offices in Milan.
Today: Farmaceutica, Regeneron: "Con nuovi uffici a Milano si consolida presenza in Italia"
Nell'ambito della strategia di espansione internazionale avviata nel 2021, Regeneron, azienda attiva nel campo delle biotecnologie, rafforza il proprio posizionamento in Italia con l'apertura dei nuovi uffici a Milano, confermando l'Italia come uno dei mercati prioritari. Fondata nel 1988 dai...
Pharmaceutical, Regeneron: "With new offices in Milan, presence in Italy is consolidated."
Within the framework of the international expansion strategy launched in 2021, Regeneron, a biotechnology company, is strengthening its position in Italy with the opening of new offices in Milan, confirming Italy as one of the priority markets. Founded in 1988 by...
Adnkronos - ultimoratop: Musilli (Regeneron): "Oncoematologia nostra priorità strategica"
(Adnkronos) - All'inaugurazione dell'hub milanese, 'lavoro su terapie potenzialmente trasformative per 30 tipi di tumori solidi e del sangue'
Musilli (Regeneron): “Oncology is our strategic priority.”
(Adnkronos) - At the Milan launch event, 'work on therapies potentially transformative for 30 types of solid and blood tumors'
Adnkronos - ultimoratop: Bramani (Regeneron): "Apriamo spazi che valorizzano chi ci lavora"
(Adnkronos) - All'inaugurazione dei nuovi uffici a Milano, 'persone motore dei risultati di business, con Sanofi collaborazione a 360 gradi'
Bramani (Regeneron): “Let’s open up spaces that value those who work here.”
(Adnkronos) - At the inauguration of the new offices in Milan, “key people driving business results, with Sanofi 360-degree collaboration.”
Adnkronos - ultimoratop: Farmaceutica, Alparone (Lombardia): "L'innovazione sceglie Milano"
(Adnkronos) - L'assessore all'inaugurazione dei nuovi uffici di Regeneron: "Capitale umano specializzato che resta in Italia"
Pharmaceutical, Alparone (Lombardy): "Innovation chooses Milan"
(Adnkronos) - The official opening of Regeneron’s new offices: “Specialized human capital that remains in Italy”
Adnkronos - ultimoratop: Farmaceutica, Regeneron: "Con nuovi uffici a Milano si consolida presenza in Italia"
(Adnkronos) - Nel nostro Paese circa 120 dipendenti e più di 30 studi clinici attivi
Pharmaceutical, Regeneron: “With new offices in Milan, presence in Italy is consolidated.”
(Adnkronos) - In our country, there are approximately 120 employees and more than 30 active clinical studies.
Here is a step-by-step guide on how to delete your data from #23AndMe before #Regeneron gets its hands on it.
https://www.eff.org/deeplinks/2025/03/how-delete-your-23andme-data
This is your most valuable and person data, protecting yourself against it being used by a for-profit pharmaceutical company is a good idea.
This week, the genetic testing company 23andMe filed for bankruptcy, which means the genetic data the company collected on millions of users is now up for sale. If you don't want your data included in any potential sale, it’s a good time to ask the company to delete it.
How to delete your 23andMe data
if you previously agreed to 23andMe and third-party researchers using your genetic data and sample for research, you can withdraw consent from the Research and Product Consents section in your account settings.
#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech
https://techcrunch.com/2025/06/11/23andme-files-for-bankruptcy-how-to-delete-your-data/
Dozens of states sue to block the sale of 23andMe personal genetic data
Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court's approval to buy the struggling firm.
#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech
https://www.npr.org/2025/06/10/nx-s1-5429041/23andme-states-lawsuit-genetic-data
Dozens of states sue to block the sale of 23andMe personal genetic data
Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court's approval to buy the struggling firm.
#Regeneron #BigPharma #23andMe #DNA #genetics #business #bankruptcy #infosec #data #bigdata #privacy #biotech
https://www.npr.org/2025/06/10/nx-s1-5429041/23andme-states-lawsuit-genetic-data
Italian News by RSS
Joe (TBA)
gtbarry